Andrew Murphy - Feb 14, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Andrew Murphy
Stock symbol
REGN
Transactions as of
Feb 14, 2022
Transactions value $
-$4,485,614
Form type
4
Date filed
2/16/2022, 03:18 PM
Previous filing
Dec 14, 2021
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1.79M +10K +17.1% $179.13* 68.5K Feb 14, 2022 Direct F1
transaction REGN Common Stock Tax liability -$4.05M -6.46K -9.43% $626.79 62K Feb 14, 2022 Direct F1
transaction REGN Common Stock Sale -$61.6K -99 -0.16% $622.09 61.9K Feb 15, 2022 Direct F1, F2
transaction REGN Common Stock Sale -$31.3K -50 -0.08% $625.90 61.9K Feb 15, 2022 Direct F1
transaction REGN Common Stock Sale -$264K -421 -0.68% $626.51 61.4K Feb 15, 2022 Direct F1, F3
transaction REGN Common Stock Sale -$395K -630 -1.03% $627.49 60.8K Feb 15, 2022 Direct F1, F4
transaction REGN Common Stock Sale -$327K -520 -0.86% $628.62 60.3K Feb 15, 2022 Direct F1, F5
transaction REGN Common Stock Sale -$335K -533 -0.88% $629.35 59.8K Feb 15, 2022 Direct F1, F6
transaction REGN Common Stock Sale -$274K -434 -0.73% $630.41 59.3K Feb 15, 2022 Direct F1, F7
transaction REGN Common Stock Sale -$117K -185 -0.31% $631.67 59.1K Feb 15, 2022 Direct F1, F8
transaction REGN Common Stock Sale -$183K -289 -0.49% $632.71 58.8K Feb 15, 2022 Direct F1, F9
transaction REGN Common Stock Sale -$139K -220 -0.37% $633.54 58.6K Feb 15, 2022 Direct F1, F10
transaction REGN Common Stock Sale -$101K -159 -0.27% $634.43 58.5K Feb 15, 2022 Direct F1, F11
holding REGN Common Stock 4.27K Feb 14, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -25% $0.00 30K Feb 14, 2022 Common Stock 10K $179.13 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F10 Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F11 Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F12 The stock option award vests in four equal annual installments, commencing one year after the date of grant.